Compliance and persistence: A comparison between typical and atypical antipsychotic treatment of schizophrenia patients

被引：0
|
作者：
Liu, GG
Sun, SX
Zhao, Z
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Walgreens Hlth Serv, Deerfield, IL USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64543-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 50 条
  • [41] Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia
    Gebhardt, Stefan
    Haertling, Fabian
    Hanke, Markus
    Theisen, Frank M.
    von Georgi, Richard
    Grant, Phillip
    Mittendorf, Markus
    Martin, Matthias
    Fleischhaker, Christian
    Schulz, Eberhard
    Remschmidt, Helmut
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2008, 17 (01) : 44 - 53
  • [42] Atypical antipsychotic adherence and hospitalization in patients with schizophrenia
    Tafesse, E
    Hines, PL
    Carson, WH
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 346 - 346
  • [43] Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia
    Stefan Gebhardt
    Fabian Härtling
    Markus Hanke
    Frank M. Theisen
    Richard von Georgi
    Phillip Grant
    Markus Mittendorf
    Matthias Martin
    Christian Fleischhaker
    Eberhard Schulz
    Helmut Remschmidt
    European Child & Adolescent Psychiatry, 2008, 17 : 44 - 53
  • [44] A comparison of an atypical (zotepine) and classical (haloperidol) antipsychotic, in patients with acute exacerbation of schizophrenia
    Raniwalla, J
    Tweed, JA
    Dollfus, S
    Petit, M
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VD5 - VD5
  • [45] Treatment adherence among patients with schizophrenia treated with atypical and typical antipsychotics
    Gianfrancesco, Frank D.
    Rajagopalan, Krithika
    Sajatovic, Martha
    Wang, Ruey-hua
    PSYCHIATRY RESEARCH, 2006, 144 (2-3) : 177 - 189
  • [46] Long-Acting Typical and Atypical Antipsychotics in Treatment of Schizophrenia: A Retrospective Comparison
    Virit, Osman
    Altindag, Abdurrahman
    Bulbul, Feridun
    Savas, Haluk Asuman
    Dalkilic, Alican
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (02): : 119 - 127
  • [47] An alternative approach to measuring treatment persistence with antipsychotic agents among patients with schizophrenia
    Ren, X. S.
    Qian, S.
    Kazis, L. E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S134 - S134
  • [48] Direct measures of changes in adiposity in schizophrenia patients during atypical antipsychotic treatment
    Schweiger, JA
    Haupt, D
    Flavin, K
    Luber, A
    Fahnestock, P
    Newcomer, JW
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 569 - 570
  • [49] Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
    Gallhofer, B
    Bauer, U
    Lis, S
    Krieger, S
    Gruppe, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 : 13 - 20
  • [50] Pharmacoeconomic studies of atypical antipsychotic drugs for the treatment of schizophrenia
    Revicki, DA
    SCHIZOPHRENIA RESEARCH, 1999, 35 : S101 - S109
12345